Skip to content
healthcare.dev

PROVENGE

NDC 30237-8900, sipuleucel-T, injection, from Dendreon Pharmaceuticals LLC.

Product NDC
30237-8900
Status
Listed
Labeler
Dendreon Pharmaceuticals LLC
Dosage form
INJECTION
Route
INTRAVENOUS
Product type
CELLULAR THERAPY
Marketing category
BLA
Application
BLA125197
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/30237-8900 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • SIPULEUCEL-T50000000 1/1

Pharmacologic classes

Autologous Cellular Immunotherapy [EPC]; Cell-mediated Immunity [PE]; Cells, Cultured, Autologous [EXT]; Leukocytes, Mononuclear [CS]

Package NDCNDC-11Package
30237-8900-6302378900061 BAG in 1 CARTON (30237-8900-6) / 1 INJECTION in 1 BAG (30237-8900-5)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=30237-8900

Use it

Look up 30237-8900 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/30237-8900 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 30237-8900. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.